XML 40 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Goodwill and Intangible Assets
 9 Months Ended
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
In connection with our new segment structure, which began in the first quarter of 2022, goodwill is now reported as part of Products & Healthcare Services or Patient Direct. There was no change to our underlying reporting units as part of that segment change and therefore no reallocation of goodwill. The following table summarizes the goodwill balances by segment and the changes in the carrying amount of goodwill through September 30, 2022:
Products & Healthcare ServicesPatient DirectConsolidated
Carrying amount of goodwill, December 31, 2021$106,280 $283,905 $390,185 
Acquisitions(532)1,249,478 1,248,946 
Currency translation adjustments(7,795)— (7,795)
Carrying amount of goodwill, September 30, 2022$97,953 $1,533,383 $1,631,336 

Intangible assets subject to amortization at September 30, 2022 and December 31, 2021 were as follows:

September 30, 2022December 31, 2021
Customer
Relationships		TradenamesOther
Intangibles		Customer
Relationships		TradenamesOther
Intangibles
Gross intangible assets$434,582 $202,000 $79,062 $275,526 $90,000 $43,189 
Accumulated amortization(182,741)(45,203)(23,623)(146,168)(33,242)(19,560)
Net intangible assets$251,841 $156,797 $55,439 $129,358 $56,758 $23,629 
Weighted average useful life12 years10 years7 years10 years11 years8 years

At September 30, 2022 and December 31, 2021, $142 million and $164 million in net intangible assets were held in the Products & Healthcare Services segment and $322 million and $45.7 million were held in the Patient Direct segment. Amortization expense for intangible assets was $14.3 million and $10.0 million for the three months ended September 30, 2022 and 2021 and $55.5 million and $30.1 million for the nine months ended September 30, 2022 and 2021. At September 30, 2022, customer relationships, tradenames, and other intangibles include preliminary estimated fair values of assets acquired as part of the Apria Acquisition.
Based on the current carrying value of intangible assets subject to amortization, estimated amortization expense is approximately $22 million for the remainder of 2022, $82 million for 2023, $65 million for 2024, $55 million for 2025, $54 million for 2026 and $47 million for 2027.